Adcetris 50 mg (Brentuximab vedotin) Injection In Pakistan

Adcetris 50mg Injection contains brentuximab vedotin, a targeted anticancer medicine used to treat certain types of lymphoma. It is an antibody-drug conjugate (ADC) that delivers a potent anticancer agent to cells expressing the CD30 protein.

Adcetris is used under the supervision of a qualified oncologist, either alone or in combination with other cancer medicines, depending on the diagnosis and treatment plan.

Product Information

• Brand Name: Adcetris

• Generic Name: Brentuximab vedotin

• Strength: 50mg per vial

• Dosage Form: Powder for concentrate for solution for infusion

• Drug Class: Antibody-drug conjugate; targeted anticancer therapy

• Route of Administration: Intravenous infusion

• Therapeutic Category: Oncology medicine

Uses of Adcetris 50mg Injection

Adcetris may be prescribed for selected cases of:

• Hodgkin lymphoma: Including certain newly diagnosed or relapsed cases.

• Systemic anaplastic large cell lymphoma (sALCL): A type of CD30-positive T-cell lymphoma.

• Other selected CD30-positive lymphomas: Depending on the approved indication and treatment protocol.

The oncologist determines whether Adcetris is appropriate based on the cancer diagnosis, disease stage, and previous treatments.

How Does Adcetris Work?

Brentuximab vedotin combines an antibody that recognizes CD30 on certain lymphoma cells with a cell-killing drug. After binding to the target cell, it delivers the drug inside the cell to help destroy it.

Dosage and Administration

• Administered by intravenous (IV) infusion only.

• The prescribed dose depends on the patient's weight, diagnosis, treatment regimen, and response.

• Treatment intervals and duration vary according to the clinical protocol.

• It must be prepared and administered by trained healthcare professionals.

Important: Adcetris is a specialist prescription medicine and must never be self-administered.

Possible Side Effects

Common or important side effects may include:

• Numbness, tingling, or weakness in the hands and feet

• Nausea, vomiting, or diarrhoea

• Fatigue and hair loss

• Low blood cell counts and increased risk of infection

• Infusion-related allergic reactions

• Liver problems

Rare but serious complications include progressive multifocal leukoencephalopathy (PML), a potentially fatal brain infection. Report new neurological symptoms or signs of a serious infection to the treating team immediately.

Precautions and Warnings

• Tell your oncologist about existing liver or kidney problems, nerve symptoms, and all other medicines being taken.

• Blood counts, liver function, and symptoms of nerve damage require monitoring.

• Adcetris must not be given together with bleomycin because of the risk of severe lung toxicity.

• The medicine requires appropriate refrigerated storage and professional preparation.